Cannara Biotech Inc. (8CB0.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:05AM CEST
| Previous close | 0.4720 |
| Open | 0.4820 |
| Bid | 0.4540 x N/A |
| Ask | 0.5100 x N/A |
| Day's range | 0.4820 - 0.4820 |
| 52-week range | 0.4660 - 0.7300 |
| Volume | |
| Avg. volume | 44 |
| Market cap | 43.916M |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 9.64 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Cannara Biotech Second Quarter 2024 Earnings: CA$0.038 loss per share (vs CA$0.007 loss in 2Q 2023)
Cannara Biotech ( CVE:LOVE ) Second Quarter 2024 Results Key Financial Results Revenue: CA$19.7m (up 51% from 2Q 2023...
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Key Takeaways; Psychedelic Sector Below is a weekly roundup on the cannabis and psychedelic sectors. In this ever-evolving landscape, we explore the major developments and groundbreaking initiatives happening among companies operating in these industries; from advancements in medical research, therapeutic applications to shifts in legal frameworks and current market trends. Top […]
- Simply Wall St.
The past five years for Cannara Biotech (CVE:LOVE) investors has not been profitable
We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly...
© 2024 Yahoo. All rights reserved.